The Pharma Legal Handbook: Denmark

Denmark combines a sophisticated pharmaceutical regulatory environment with one of Europe's most tightly controlled pricing and reimbursement systems. The Danish Medicines Agency (DKMA) applies rigorous standards to product authorisation, and reimbursement decisions are made through a structured health technology assessment process that requires careful preparation and local expertise.

The Pharma Legal Handbook: Denmark provides a comprehensive, practice-oriented guide to pharmaceutical regulation in Denmark. It covers product licensing and authorisation, clinical trial requirements, pricing and reimbursement pathways, pharmacovigilance obligations, manufacturing standards, marketing rules, parallel imports, and intellectual property protection.

Denmark is also notable as a market where parallel imports are commercially significant and where the rules around generic substitution and pharmacy-level switching have direct revenue implications for brand holders.

If legal handbook content is updated, you will receive an updated PDF free for up to one year after purchase.